BARCELONA, Spain — A large amount of real-world data collected from clinics across the U.K. highlighted the effectiveness, safety and durability of faricimab for diabetic macular edema in treatment-naive and previously treated eyes.
“These data are specific to the U.K. so may not be readily generalizable in other countries, but we’re very proud to have been able to achieve such a safe administration of the drug under pretty trying circumstances,” Tunde Peto, MD, PhD, said at the Euretina congress.
The FARWIDE-DME retrospective real-world study collected data between July